BLK vs LULU: Which Is the Better Buy?

Side-by-side comparison of BlackRock, Inc. and Lululemon Athletica Inc. โ€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-21.
BlackRock, Inc. ยท Financial Services
$1,069.78
+44.0% upside to fair value
High Conviction Grade A High Quality
VS
Lululemon Athletica Inc. ยท Consumer Cyclical
$98.06
+1.5% upside to fair value
Low Conviction Grade C
QuantHub Verdict
BLK has more upside to fair value (+44.0%). These are model outputs โ€” not personalized investment advice. See all research โ†’
Valuation & Fundamentals
Metric BLK LULU
Current Price $1,069.78 $98.06
Fair Value Estimate $1,540.94 $99.50
Upside to Fair Value +44.0% +1.5%
Market Cap $165.8B $11.1B
Forward P/E โ€” โ€”
EV / EBITDA 15.9x 4.6x
Price / Sales 6.1x 1.0x
Price / FCF 71.5x 8.2x
Revenue Growth YoY +30.6% -4.3%
Gross Margin 55.7% 56.1%
Operating Margin 31.1% 17.8%
Return on Equity 11.7% 29.7%
Dividend Yield 2.09% 0%
FCF Yield 1.4% 12.24%
Analyst Consensus Strong Buy Sell
Investment Thesis
BLK โ€” BlackRock, Inc.
BlackRock is the world's largest asset manager, overseeing $15.345 trillion in assets across ETFs, active strategies, alternatives, and the Aladdin investment-technology platform, serving institutional, intermediary, and individual clients globally. The business quality is high: TTM gross margin of 55.7%, operating margin of 31.1%, and net margin of 24.1% reflect the scalability of a fee-based moโ€ฆ
LULU โ€” Lululemon Athletica Inc.
Lululemon Athletica designs and retails premium athletic apparel and accessories through company-owned stores and direct-to-consumer channels, with roughly 39,000 employees and a brand built on technical fabrics and community-led fitness positioning. The business still earns high returns on equity of 29.7% and generates $12.00 of free cash flow per share on $97.70 of revenue per share, with TTM gโ€ฆ
Accumulation Zones
Metric BLK LULU
Zone Low $1,155.70 $74.62
Zone High $1,309.80 $84.58
In Buy Zone? Yes No
โ† BLK Research    LULU Research โ†’    All Research